Once-daily, effective, safe, and well-tolerated ZORYVE cream 0.05% now commercially available for children as young as age 2ZORYVE cream 0.05% ...
Roflumilast cream may be suitable for chronic treatment, including the face and intertriginous areas, according to one study. Once-daily roflumilast cream 0.3% in adults with chronic plaque psoriasis ...
Daré Bioscience, in collaboration with Strategic Science & Technologies, announced plans for a Phase 3 clinical study of Sildenafil Cream, 3.6%, aimed at treating female sexual arousal disorder (FSAD) ...
The FDA rounded out the month with the approval of remibrutinib (Rhapside; Novartis), a highly selective Bruton tyrosine kinase inhibitor (BTKi), for patients with chronic spontaneous urticaria (CSU) ...
Zoryve (roflumilast) cream 0.15 percent can help improve itch, the most bothersome atopic dermatitis symptom, in as soon as 24 hours. Side effects were minimal and mild in clinical trials. Because ...
The delicate skin around our eyes tells stories of sleepless nights, stress, and the passage of time. Modern dermatological research reveals that this area contains the thinnest skin on our bodies, ...
The next generation of groundbreaking weight loss drugs is just over the horizon - and they won't require needles. Roughly 12 million people have taken Ozempic ...
Explore four premium hair creams and gels available on Myntra that repair, hydrate, and style your hair. From curl enhancers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results